John C. Cheneval
Corporate Officer/Principal chez CASTLE BIOSCIENCES, INC.
Profil
John C.
Cheneval is currently working as the Executive Director-Business Development at Castle Biosciences, Inc. Prior to his current position, he worked as the Vice President-Pharma Partnerships at HTG Molecular Diagnostics, Inc. from 2018 to 2021.
He also served as the Executive Vice President-Sales & Marketing at Akers Biosciences, Inc. In terms of education, Mr. Cheneval completed his undergraduate degree at LSU Medical School and Louisiana State University.
Postes actifs de John C. Cheneval
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2021 |
Anciens postes connus de John C. Cheneval
| Sociétés | Poste | Fin |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| MYMD PHARMACEUTICALS, INC. | Sales & Marketing | - |
Formation de John C. Cheneval
| Louisiana State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Akers Biosciences, Inc.
 Akers Biosciences, Inc. Medical SpecialtiesHealth Technology Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in New York, NY. | Health Technology |
